Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KILITCH DRUGS vs SYSCHEM (I). - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KILITCH DRUGS SYSCHEM (I). KILITCH DRUGS/
SYSCHEM (I).
 
P/E (TTM) x 35.1 -298.8 - View Chart
P/BV x 2.8 2.8 100.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KILITCH DRUGS   SYSCHEM (I).
EQUITY SHARE DATA
    KILITCH DRUGS
Mar-24
SYSCHEM (I).
Mar-24
KILITCH DRUGS/
SYSCHEM (I).
5-Yr Chart
Click to enlarge
High Rs47074 635.8%   
Low Rs14136 388.2%   
Sales per share (Unadj.) Rs96.041.1 233.6%  
Earnings per share (Unadj.) Rs8.40.7 1,218.8%  
Cash flow per share (Unadj.) Rs10.51.4 755.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs109.414.3 765.7%  
Shares outstanding (eoy) m16.0839.86 40.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.21.3 237.3%   
Avg P/E ratio x36.279.6 45.5%  
P/CF ratio (eoy) x29.039.6 73.3%  
Price / Book Value ratio x2.83.9 72.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m4,9122,197 223.6%   
No. of employees `000NANA-   
Total wages/salary Rs m10061 164.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,5441,638 94.2%  
Other income Rs m452 2,634.7%   
Total revenues Rs m1,5891,640 96.9%   
Gross profit Rs m24370 347.4%  
Depreciation Rs m3428 120.1%   
Interest Rs m603 2,385.8%   
Profit before tax Rs m19441 470.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5814 427.4%   
Profit after tax Rs m13628 491.7%  
Gross profit margin %15.74.3 368.7%  
Effective tax rate %29.932.9 90.9%   
Net profit margin %8.81.7 521.7%  
BALANCE SHEET DATA
Current assets Rs m1,4601,263 115.5%   
Current liabilities Rs m642968 66.4%   
Net working cap to sales %53.018.1 293.5%  
Current ratio x2.31.3 174.1%  
Inventory Days Days1735 3,758.1%  
Debtors Days Days1,4951,525 98.1%  
Net fixed assets Rs m915367 249.1%   
Share capital Rs m161399 40.3%   
"Free" reserves Rs m1,599171 935.2%   
Net worth Rs m1,759570 308.9%   
Long term debt Rs m05 0.0%   
Total assets Rs m2,3751,631 145.6%  
Interest coverage x4.217.3 24.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.61.0 64.7%   
Return on assets %8.31.8 446.8%  
Return on equity %7.74.8 159.1%  
Return on capital %14.47.6 189.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7790-   
Fx outflow Rs m1660-   
Net fx Rs m6130-   
CASH FLOW
From Operations Rs m-1-256 0.6%  
From Investments Rs m-95-65 147.6%  
From Financial Activity Rs m88316 27.8%  
Net Cashflow Rs m-9-5 186.1%  

Share Holding

Indian Promoters % 69.2 53.2 130.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.2 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.8 46.8 65.7%  
Shareholders   9,920 13,305 74.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KILITCH DRUGS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on KILITCH DRUGS vs SYSCHEM (I).

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

KILITCH DRUGS vs SYSCHEM (I). Share Price Performance

Period KILITCH DRUGS SYSCHEM (I). S&P BSE HEALTHCARE
1-Day 0.19% 0.83% 1.23%
1-Month 0.72% 4.26% -0.24%
1-Year -3.12% -20.44% 43.62%
3-Year CAGR 26.35% 50.19% 20.35%
5-Year CAGR 21.72% 42.49% 26.24%

* Compound Annual Growth Rate

Here are more details on the KILITCH DRUGS share price and the SYSCHEM (I). share price.

Moving on to shareholding structures...

The promoters of KILITCH DRUGS hold a 69.2% stake in the company. In case of SYSCHEM (I). the stake stands at 53.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of KILITCH DRUGS and the shareholding pattern of SYSCHEM (I)..

Finally, a word on dividends...

In the most recent financial year, KILITCH DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

SYSCHEM (I). paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of KILITCH DRUGS, and the dividend history of SYSCHEM (I)..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.